Combined analgesic regimens produce sufficient analgesia by additive or synergistic effects, and reduce the total dose of analgesics and minimise adverse effects. We investigated the metamizole, paracetamol and morphine combination with respect to postoperative pain treatment in lumbar disc surgery. MATERIAL and METHODS: After Ethics Committee approval and informed consent, 63 patients were allocated to three treatment groups; as Group paracetamol: paracetamol (1 g), Group paracetamol-metamizole: paracetamol (1 g) and metamizole (1 g), and Group placebo: no analgesic. All the patients received intravenous (i.v.) morphine with a patient-controlled analgesia device (PCA) as the rescue analgesic. Pain was assessed by the numerical pain rating scale (NRS, 0-3). Total morphine consumption at 24 hours, patient satisfaction and side effects were investigated. RESULTS: NRS of Group paracetamol-metamizole was low at 15th min, 30th min and 1st hour, and the difference reached statistical significance at 30th min (p=0.033). Patient satisfaction at the same measurement times was high in this group. Total morphine consumption and side effects were not statistically different between the three groups. CONCLUSION: Addition of metamizole to paracetamol along with iv morphine PCA offers an advantage over single iv morphine PCA and paracetamol, with respect to early postoperative pain treatment and patient satisfaction.
INTRADUCTION
Systemic administrations of analgesics is the most widely used method to reduce postoperative pain after lumbar disc surgery. Opioids and nonsteroidal anti-inflammatory drugs (NSAIDs) play an important role in reducing postoperative pain (8) . A combination of analgesics produces additive or synergistic effects and provides sufficient analgesia. Combined regimens can reduce the total dose of analgesics and minimize the adverse effects (4) . The combination of opioid, NSAIDs and paracetamol reduces the postoperative opioid requirement and decreases the incidence of opioidinduced side effects (6) . The paracetamol and NSAIDs combination is widely used clinically, but what this combination offers is still a matter of debate (19) .
There are studies reporting that the addition of metamizole to morphine would potentiate morphine's antinociceptive effects (2, 9, 14) . However, the combination of metamizole (NSAID), paracetamol and morphine has not been evaluated previously with respect to postoperative pain control after lumbar disc surgery.
Previous studies have investigated a combination of paracetamol with intravenous (i.v.) morphine patient-controlled analgesia (PCA). There are conflicting results about this combination with respect to its opioid-sparing effect (4, 11, 18) .
The aim of this study was to investigate the effects of addition of i.v. metamizole to i.v. paracetamol along with i.v. morphine PCA in respect to total morphine consumption, pain alleviation and patient satisfaction after lumbar disc surgery.
MATERIAL and METHODS
After obtaining Ethics Committee approval and informed consent, 63 patients ASA I-II (American Society of Anesthesiologists), scheduled for singlelevel, unilateral lumbar disc surgery were informed about the use of the PCA device and the numeric pain rating scale (NRS). Patients with impairment in liver function, renal dysfunction, hypersensitivity or contraindication to the study drugs, or history of lumbar disc re-operations and the patients who would be operated on by residents were excluded. Only the operations of the senior experienced surgeons were included in the study. Patients were randomized to one of three treatment groups in a double-blind manner using a computerized allocation schedule and unlabeled syringes. After randomization, an anesthetist not involved in the patients care or data collection, prepared the unlabeled syringes and gave them to the anesthetist dealing with the patient care. In Group paracetamol-metamizole (Group PM), 1 g paracetamol (Perfalgan, 10 mg.ml -1 ) was infused by a perfusor set to deliver 400 ml.hour -1 over 15 min to enable double blindness at the end of the operation and i.v. 1 g metamizole (Adepiron, 500 mg.ml -1 ) was injected during the skin closure. In Group paracetamol (Group P), paracetamol 1g was infused in the same manner as in the previous group and 2 ml 0.9% NaCl i.v. was injected instead of metamizole. In Group placebo (Group C) no drug was administered. All the patients received morphine PCA as the rescue analgesic; loading dose 1 mg, bolus dose 1 mg, lock-out interval 10 min, 4 hour (h) limit 20 mg, no background infusion. The device was connected immediately to all groups upon arrival at the postanesthesia care unit. The time elapsed from the end of surgery to the beginning of PCA was approximately 10-15 min.
A blinded observer recorded pain, cumulative morphine consumption, adverse effects (nausea, vomiting, shivering, urinary retention) and patient satisfaction at postoperative 15 and 30 min, 1 h, 2 h, 6 h and 24 h.
Pain was evaluated by NRS as: 0: no pain, 1: mild pain, 2: moderate pain, and 3: severe pain.
Patient satisfaction with postoperative pain management was assessed by a 4-point rating scale as: 0: poor, 1: moderate, 2: good, and 3: excellent.
STATISTICAL ANALYSIS
The SPSS 15.0 for Windows statistical package (SPSS Inc., Chicago, IL, USA) was used for all analyses. Patient characteristics, duration of the procedure, pain scores, postoperative morphine consumption, and morphine requests were analyzed using analysis of variance, Kruskal-Wallis test and Χ 2 -test, where appropriate. Normal distribution of numerical data was assessed using the Shapiro-Wilk test. Significance was determined at the p<0.05 level. The Bonferroni approach was used for multiple comparisons. Results are given as medians (range) for non-parametric data and as mean ± standard deviation (SD) for continuous data. The number of patients (approximately 20 patients per group) was assumed to detect (with 80% power and 5% type-1 error level) a 1-point difference in NRS scores (mean NRS score of 2 and assuming an SD of 1 in all groups) between the groups.
RESULTS
In total, the results of 63 patients were analyzed and no patient was excluded. Twenty patients were enrolled in Group C, 20 in Group P and 23 in Group PM. Patient characteristics, duration of surgery and anesthesia, and total intraoperative fentanyl use were similar among the groups (Table I) .
We observed differences among the groups, with respect to NRS scores at 15 min, 30 min and 1 h, but the difference reached statistical significance only in the PM group at 30 min (Kruskal-Wallis test, p=0.033 with post hoc Mann-Whitney U tests having p values of 0.018 and 0.038 for comparisons versus Groups C and P, respectively, Figure 1 ). The scores were similar at observations beyond 1 h, i.e. at 2 h, 6 h and 24 h (Table II) . Median NRS scores at 2 h were 1 (0-3) in all groups indicating mild pain.
In Group PM, cumulative morphine use in two patients at 6 h was 36 mg and 23 mg, causing an increase in 24 h morphine consumption (Figure 2 ). Total morphine use at 24 h was 23.6±19.3 mg, 15.6±11.7 mg and 18±12.8 mg in Groups C, P and PM respectively (not significant, Figure 1) Patient satisfaction scores were significantly higher at 15 min, 30 min, 1 h and 2 h (Kruskal-Wallis test, p=0.005, 0.002, 0.003 and 0.042, respectively) in Group PM when compared with Groups P (MannWhitney U test, p=0.003, 0.001, 0.003 and 0.021, respectively) and C (Mann-Whitney U test, p=0.009, 0.009, 0.004 and 0.042, respectively) (Table III) . Median patient satisfaction scores at 30th min were 1.5 (0-3), 1 (0-3), 2 (1-3) in Groups C, P, PM respectively and increased to 3 at 24 h in all groups.
Morphine demand in Group C was higher than in the other groups at all evaluation times with no statistical significance (Figure 2) . In Group C, one patient's morphine demand was 941 and two patients' demand was 398, causing an extreme increase in the total number of demands.
There were no statistically significant differences in the incidence of nausea, vomiting, shivering, or urinary retention between the groups (Table IV) .
DISCUSSION
This study showed that pain control was similar with the combination of iv paracetamol and i.v. morphine PCA compared to i.v. morphine PCA alone, but addition of metamizole provided better the early pain scores in the first postoperative two hours and increased patient satisfaction. In the early postoperative period, combination of metamizole and paracetamol with morphine PCA provided better pain control and better patient satisfaction.
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NSAIDs and paracetamol have been widely used for multimodal analgesia in the postoperative period (4, 19) . NSAIDs show their effects by inhibiting peripheral cyclooxygenase (COX). The COX enzyme has COX-1 and COX-2 subtypes. NSAIDs reduce prostaglandin synthesis in peripheral tissues by inhibition of the COX enzyme in the arachidonic acid metabolism (8, 19) . Metamizole is a nonselective COX-2 inhibitor with good tolerability. COX-2 inhibitors are thought to have a lower risk/benefit ratio than traditional NSAIDs (8) . In recent studies, COX-3 has been described as a variant of COX-1, which has a role in the paracetamol mechanism (20, 23) . The combination of paracetamol with diclofenac, ketoprofen, ketorolac, suprofen and tenoxicam provided more effective analgesia than paracetamol alone (7, 12, 15) .
Paracetamol is a relatively safe nonopioid analgesic despite hepatic cell injury following highdose administration (22) . Paracetamol interacts with the serotonergic system and is a centrally acting inhibitor of COX. It may be used alone or in combined analgesic regimens for the treatment of mild and moderate postoperative pain (4, 11). Oral, rectal and in i.v. forms of paracetamol have been available. In this study, the combination of paracetamol with metamizole and morphine PCA was investigated. Single-dose metamizole at the end of the operation along with paracetamol and morphine PCA provided better pain control. Repeated doses of metamizole would possibly provide prolonged pain control.
Metamizole is a pyrazoline-derived non-opiate analgesic drug with antipyretic and spasmolytic features. It is a widely used injectable nonopioid analgesic for postoperative pain therapy in several European countries with a low incidence of adverse reactions, but a risk of agranulocytosis. The incidence of this side effect is a matter of debate (5) and may be dependent on genetic factors, and the real incidence of agranuloscytosis due to metamizole is not known (8) . Metamizole is not approved for pain therapy in the United States and Scandinavian countries. Agranulocytosis was not observed in our The effect of i.v. paracetamol on postoperative analgesia is a questionable. Sinatra et al. (21) found that visual analogue scale (VAS) score and morphine consumption were decreased, while side effects were not changed in the postoperative 24 hours following 1 g i.v. paracetamol and 2 g i.v. proparacetamol in patients undergoing major orthopedic surgery. Hernandez-Palazon et al.(10) gave 2 g proparacetamol per 6 hours for 3 days following spinal fusion surgery, and found that morphine consumption and pain score were significantly decreased. Many studies have found that addition of paracetamol to morphine did not decrease the pain score or morphine consumption (4, 8, 18) . The effect of non-opioid analgesics is dependent on the type of surgery performed. After retinal surgery, the analgesic potency of paracetamol is comparable to that of metamizole (13) , whereas after lumbar microdiscectomy, the analgesic potency of paracetamol was inferior to metamizole (8) . In contrast with the mentioned study, we added metamizole to paracetamol and found a more pronounced pain relief after lumbar discectomy. We found no difference between placebo and paracetamol groups in respect to postoperative pain treatment. This result was similar to that of Grungmann et al (8) . It was expected that total morphine consumption would be lowest in Group PM as NRS of scores of pain were better in the early postoperative period. Although not significant, Group PM's morphine use was higher than expected. This is because two patients in Group PM used 36 mg and 23 mg morphine at 6 h (cumulative dose) hour causing an increase in total 24 h morphine use.
The PCA device lock-out period was 10 min and a 4 h limit was set to 20 mg (1 h morphine limit 5 mg and 24 h limit 120 mg). No patient in the study used 120 mg morphine in the 24 h period in any group. The maximum doses used in 24 h were 55 mg in Group C (one patient), 44 mg in Group P (one patient) and 42 mg in Group PM (one patient).
Hernandez-Delgadillo et al (9) found that single and repeated doses of metamizole increased the duration of the antinociceptive effects of morphine and potentiated its effects. The mechanisms of the acute antinociceptive synergistic effects of metamizole and morphine are not known. Peripheral activation of the arginine-nitric oxidecyclic guanosine monophosphate pathway may play a role in the antinociceptive synergistic effects of morphine and metamizole (1). In our study, metamizole was administered once at the end of the operation. Although total morphine consumption in 24 hours was the same in all groups, early pain control was better in the PM group, and this may be due in part to the synergistic effect of metamizole and morphine. Further studies should be conducted to investigate the 24 h morphine use if metamizole is given in repeated doses to patients undergoing lumbar disc surgery. According to Montané's (17) review article on postoperative pain therapy after traumatic orthopedic surgery (TOS), evidence regarding pain therapy after TOS was insufficient to identify the best method. It was mentioned that single-dose regimens of drugs were mostly studied, as in our study. This was the usual practice in our hospital, while prolonged postoperative pain therapy was usually under the purview of the neurosurgical department. Thus, the results of the study might be more easily applicable to routine clinical practice. The safety, route of administration, and length of action of the drug should be taken into consideration for the best treatment option.
